Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7415 p241
26 August 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Responses: Society (PDF 70K) and PSNC
MHRA Consultation


Society and PSNC support plans to scrap CD script retention

Both the Royal Pharmaceutical Society and the Pharmaceutical Services Negotiating Committee support plans to scrap the requirement for pharmacies to keep prescriptions for Schedule 2 and 3 Controlled Drugs for two years after they have been dispensed.

The rule, set down in the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980, is to be dropped so that the recently introduced special CD prescription forms can be sent to NHS prescription pricing organisations for monitoring, as recommended by the Shipman Inquiry.

But the Society is concerned that the proposal leaves open the question of whether pharmacies might have to photocopy such prescriptions and keep the copies, as well as send the originals for monitoring.

The Society is also worried that NHS pricing bodies do not have consistent policies on how long they keep prescriptions. Currently, prescriptions from England will be kept for 14 months, while those from Wales are kept for a year. In future, Welsh prescriptions will only be kept for three months, after which an electronically scanned copy will be kept. The Society takes the view that all original prescriptions should be kept by the pricing authorities for 12 months, so that they are available if investigations have to be carried out.

Back to Top


©The Pharmaceutical Journal